Hepatitis B Virus (HBV) Market Size and Forecast 2024-2033| Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmon La Roche Ltd., Merck & Co. Inc., AbbVie Inc

Hepatitis virus with human liver on medical background. 3d illustration

Overview and Scope

Hepatitis B virus (HBV) is a viral infection targeting the liver, transmitted via exposure to contaminated blood or bodily fluids or vertical transmission from mother to child during childbirth. Treatment involves antiviral medications to suppress viral replication, with vaccination being a crucial preventive measure.

Sizing and Forecast

The hepatitis b virus (hbv) market size has grown rapidly in recent years. It will grow from $6.04 billion in 2023 to $6.71 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising prevalence of hepatitis b virus (hbv), growing demand for hbv diagnostics, expanding hbv vaccine coverage, rising awareness of hepatitis b virus (hbv)

The hepatitis b virus (hbv) market size is expected to see strong growth in the next few years. It will grow to $9.71 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rise of personalized medicine, growing support from patient advocacy groups, rising vaccination programs, increase in healthcare expenditure. Major trends in the forecast period include development of new drugs, advancements in diagnostic technologies, public-private partnerships, innovative biological therapies.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report

Segmentation & Regional Insights

The hepatitis b virus (hbv) market covered in this report is segmented –

1) By Type: Acute; Chronic

2) By Treatment: Immune Modulator Drugs; Antiviral Drugs; Vaccine; Surgery

3) By Age Group: Pediatrics; Adults; Seniors

4) By End User: Medical Providers; Patients; Healthcare Payers

North America was the largest region in the hepatitis B Virus (HBV) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hepatitis B virus (HBV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12867&type=smp

Major Driver Impacting Market Growth

The high prevalence of hepatitis B infection is expected to propel the growth of the hepatitis B virus market going forward. Hepatitis B is a liver infection brought on by the hepatitis B virus (HBV), which is prevented through vaccination. Rising hepatitis B infection rates can increase demand for diagnostic tests and treatment options. For instance, in December 2022, according to the European Centre for Disease Prevention and Control, a Sweden-based agency for strengthening Europe’s defenses against infectious diseases, hepatitis B virus (HBV) infection was recorded in 16,187 cases in 30 Eastern European Member States in 2021. Further, the total cases 15,380 equal a crude rate of 4.7 cases per 100,000 people, compared to 14,332 in 2020. Therefore, the high prevalence of hepatitis B infection will drive the hepatitis B virus market.

Key Industry Players

Major players in the hepatitis b virus (hbv) market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmon La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Eisai Co. Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Celltrion Inc., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arrowhead Pharmaceuticals Inc., Arbutus Biopharma Corporation, Globeimmune Inc., Antios Therapeutics Inc.

The hepatitis b virus (hbv) market report table of contents includes:

1. Executive Summary

2. Hepatitis B Virus (HBV) Market Characteristics

3. Hepatitis B Virus (HBV) Market Trends And Strategies

4. Hepatitis B Virus (HBV) Market – Macro Economic Scenario

5. Global Hepatitis B Virus (HBV) Market Size and Growth

26. South America Hepatitis B Virus (HBV) Market

27. Brazil Hepatitis B Virus (HBV) Market

28. Middle East Hepatitis B Virus (HBV) Market

29. Africa Hepatitis B Virus (HBV) Market

30. Hepatitis B Virus (HBV) Market Competitive Landscape And Company Profiles

Top Major Players: